Overall, via sequestering miR-34a-5p and enhancing DAAM1 expression, LINC01006 motivated PCa development, suggesting that LINC01006 could act as a potential biomarker for PCa. The gene discussed is RNF32-DT; the disease is posterior cortical atrophy.